Today

Agents

Chat

Arena

Discover

More

App

Adaptive Biotechnologies Q2 EPS USD -0.25 - ADPT News | Rallies

Adaptive Biotechnologies Q2 EPS USD -0.25

ADPT•2026-07-29

Q2 financial results

Jul. 29 (Reuters) - Adaptive Biotechnologies Q2 revenue was USD 71.553 million vs. IBES estimate USD 65.9 million.

Q2 operating expenses: USD 87.323 million
Q2 net income: USD -39.941 million
Q2 operating income: USD -15.77 million
Q2 adjusted EBITDA: USD -700 thousand

Related News

CVR Partners posts Q2 net income of $78 million, declares $6.08 distribution per unit

UAN•2026-07-29

AXT lowers shareholder meeting quorum requirement to 33.33% from majority

AXTI•2026-07-29

Smartbird replaces Deloitte with BPM as auditor after RFP process

•

2026-07-29

Bel Fuse Q2 FY26 net sales rise 25.1% to 210.7 million; GAAP net earnings attributable to shareholders fall 5.1% to 25.5 million

BELFB•2026-07-29

Saba Capital Management acquires 2,608 Mexico Fund common shares for $56,252.48

MXF•2026-07-29